To amend title XVIII of the Social Security Act to establish a full risk ACO program.

HR8129, introduced March 26, 2026 by Rep. Tenney (R-NY) with one cosponsor, would amend the Social Security Act to establish a permanent full risk ACO program in traditional Medicare with standard and complex care (6+ chronic conditions) tracks. The bill mandates HHS implementation by June 30, 2026. It is currently referred to Ways and Means and Energy and Commerce — early stage with no hearings or markups. The bill does not authorize a specific funding amount; it creates a payment model mechanism, meaning Congressional Budget Office scoring would estimate Medicare savings, not new appropriations.

The money trail is indirect — this is not a direct spending bill. Full risk ACOs shift Medicare fee-for-service beneficiaries into capitated arrangements where participating ACOs bear financial risk for total cost of care. The winners are insurers and provider organizations that already operate Medicare Advantage plans or risk-bearing ACOs, because they have the actuarial, care management, and network infrastructure to administer full risk contracts profitably.

Structural winners are exactly the four tickers: $UNH (largest MA insurer, Optum provider network, and Optum Rx PBM), $HUM (85% MA revenue concentration, CenterWell clinics), $CNC (Medicaid/dual-eligible managed care infrastructure transferable to complex care track), and $CVS (Aetna + Oak Street + Signify integrated model). No structural losers in managed care; traditional fee-for-service providers (e.g., independent hospitals) could face margin compression if they cannot bear full risk, but this is not a direct negative for any publicly traded company.

Market data: The 30-day moves are extraordinary — $CNC +62.34% ($38.17 to $53.15), $HUM +38.49% ($205.14 to $240.13), $UNH +35.85% ($324.63 to $367.61), $CVS +16.05% ($77.30 to $83.35). The acceleration is concentrated in the last 7 days — $CNC +27.09%, $HUM +11.57%, $CVS +6.94%, $UNH +3.58%. This suggests the bill's introduction on 3/26 may have been a catalyst, but the larger rally likely reflects broader sector rotation into managed care on anticipated Medicare Advantage rate finalization and value-based care policy tailwinds, not solely this early-stage bill.

Timeline: HR8129 is at least 4-6 months from potential passage in the 119th Congress. It needs hearings, markup, House floor vote, Senate companion bill, conference, and presidential signature. With only 1 cosponsor and 2 committee referrals, chances of passage this session are low without significant sponsor coalition building.